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Abstract
Bacterial infections remain a threat to human and animal health worldwide, and there is an urgent need to find novel
targets for intervention. In the current study we used a computer model of the metabolic network of Salmonella enterica
serovar Typhimurium and identified pairs of reactions (cut sets) predicted to be required for growth in vivo. We termed such
cut sets synthetic auxotrophic pairs. We tested whether these would reveal possible combined targets for new antibiotics
by analyzing the performance of selected single and double mutants in systemic mouse infections. One hundred and two
cut sets were identified. Sixty-three of these included only pathways encoded by fully annotated genes, and from this sub-
set we selected five cut sets involved in amino acid or polyamine biosynthesis. One cut set (asnA/asnB) demonstrated
redundancy in vitro and in vivo and showed that asparagine is essential for S. Typhimurium during infection. trpB/trpA as
well as single mutants were attenuated for growth in vitro, while only the double mutant was a cut set in vivo, underlining
previous observations that tryptophan is essential for successful outcome of infection. speB/speF,speC was not affected
in vitro but was attenuated during infection showing that polyamines are essential for virulence apparently in a growth
independent manner. The serA/glyA cut-set was found to be growth attenuated as predicted by the model. However, not
only the double mutant, but also the glyA mutant, were found to be attenuated for virulence. This adds glycine production
or conversion of glycine to THF to the list of essential reactions during infection. One pair (thrC/kbl) showed true redundancy
in vitro but not in vivo demonstrating that threonine is available to the bacterium during infection. These data add to the
existing knowledge of available nutrients in the intra-host environment, and have identified possible new targets for
antibiotics.
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Introduction
Despite substantial progress in infection biology research over
the last decades, bacterial infections remain a major threat to
human and animal health worldwide. With the rapid evolution
and spread of antimicrobial resistance [1,2], development of new
strategies to fight bacterial infections is urgently needed.
Bacterial metabolism constitutes a recent area of interest with
regard to host-pathogen interactions because of the potential of
identifying novel anti-infective targets that inhibits pathogen
survival in the host [3–6]. However, knowledge about the
nutritional environment inside the host has for most pathogens
only been scarcely described, and the majority of this knowledge
has been inferred from gene expression studies of host-pathogen
interactions in cell cultures or investigated through virulence
studies of a limited number of specific auxotrophic mutants [7–
12].
System level approaches describing the metabolic capacities of
bacterial pathogens has revealed that bacterial metabolism can be
highly robust with extensive redundancies, not only within the
pathogen but also between the pathogen and the host [13–17]. As
a consequence, the identification of new essential metabolic targets
for treatment of bacterial infections has been challenging [18]. To
meet this challenge it has been proposed to target reactions in
redundant pathways constituting cut sets [19], i.e. sets of metabolic
reactions that when removed from the organism in conjunction
proves detrimental, while each of them are dispensable. Cut sets
could be of any size, but for development of antimicrobial agents,
cut sets above two reactions are impractical. In the case where a
pair of redundant reactions can be removed from the network by
deleting exactly two genes, these genes are referred to as a
synthetic lethal pair when they cause absolute absence of growth
[20]. Since we identify pairs of reactions that cause inability to
grow in defined minimal medium, we have coin the term
‘‘synthetic auxotrophic’’ and use that to describe the situation
where the model predicts no growth when exactly two genes are
removed.
PLOS ONE | www.plosone.org 1 July 2014 | Volume 9 | Issue 7 | e101869
Exhaustive identification of synthetically auxotrophic pairs
using purely experimental approaches would involve constructing
and characterizing many thousands of mutant strains, which is, if
not infeasible, cumbersome. Also, since this approach would be
limited to combinations of two genes, possible combinations of
pairs of enzymes encoded by redundant genes would be missed.
An alternative, explored here, is to use a computer model of the
metabolic network and identify pairs of reactions that when
removed from the network renders it incapable of synthesizing
biomass, i.e. cut sets. Here we investigate the metabolic network of
Salmonella enterica serovar Typhimurium (S. Typhimurium) using a
published genome-scale metabolic model (GSM) [21]. GSMs are
models involving all metabolic reactions available to an organism,
ultimately encoded by its genome. GSMs published today are
stoichiometric models, owing to the lack of system-wide kinetic
data for most metabolic systems [22,23]. The only knowledge
required for construction of stoichiometric models is the structure
of the network, i.e. the reactions involved and their stoichiometry.
Construction and analysis of metabolic models for bacteria have
been reviewed by Durot et al. [24].
In the current study we have combined in silico metabolic
modeling to identify predicted redundancies in pathways in the
metabolism with a targeted validation by infection experiments
with selected synthetic auxotrophic pairs involved in amino acid
and polyamine biosynthesis. Specifically, we have used S.
Typhimurium as a model to investigate the role of 5 cut sets,
suggested by computational analysis. Results have disclosed
specific information about the available nutrients in the host
environment, and we have identified potential novel combined
targets for antimicrobial therapy.
Methods
Bacterial strains and growth conditions
S. Typhimurium 4/74 was used as wild-type strain in all
experiments. This strain has been described previously and its
virulence is well defined [25]. The restriction deficient strain S.
Typhimurium KP1274 was used as primary recipient for plasmids
[26]. S. Typhimurium strains were maintained in LB media
(Oxoid). For solid medium, 1.5% agar was added to give LB agar
plates. Chloramphenicol (10 mg ml21), kanamycin (50 mg ml21) or
carbenicillin (75 mg ml21) was added as required. Growth
phenotypes were investigated in LB (Difco), M9 minimal media
(2 mM MgSO4, 0.1 mM CaCl2, 0.4% glucose, 8.5 mM NaCl,
42 mM Na2HPO4, 22 mM KH2PO4, 18.6 mM NH4Cl) or
M9 minimal media supplemented with 50 mg/l alanine, thia-
Table 1. In vitro and in vivo phenotypes of cut sets.
Synthetic auxotrophic pair# Mutant genotype¤ Growth
$
Competitive index (CI)¥
LB M9 M9+£
(72)a ASNSYNB-RXN, ASNSYNA-RXN DSTM3877 (asnA) + + + 1.33+/20.53
DSTM0680 (asnB) + + + 0.61+/20.29
DSTM0680/STM3877 + - - 0.05+/20.009*
DasnA/asnB+pSLD64-asnA nd + + 0.33+/20.18**
(2) PGLYCDEHYDROG-RXN,
GLYOHMETRANS-RXN
DSTM3062 (serA) + - + 1.02+/20.15
DSTM2555 (glyA) + - + 0.02+/20.02*
DSTM3062/STM2555 + - - 0.01+/20.01*
serA/glyA +pACYC177-glyA nd nd nd 0.5+/20.17**
(14) THRESYN-RXN, AKBLIG-RXN DSTM0004 (thrC) + (+) (+) 0.87+/20.18
DSTM3709 (kbl) + + + 0.61+/20.31
DSTM0004/STM3709 + - - 0.88+/20.22
(11) AGMATIN-RXN, ORNDECARBOX-RXN DSTM3078 (speB) + + + 0.37+/20.15
DSTM0701 (speF)/STM3114 (speC) + + + 1.26+/20.53
DSTM3078/STM07017+STM3114 + + + 0.0+/20
(36) TRYPSYN-RXN DSTM1727 (trpA) + - - 1.27+/20.0
DSTM1727+pACYC1727-trpA + + nd nd
DSTM1726 (trpB) + - - 1.44+/20.23
DSTM1726+pACYC1726-trpB + (+) nd nd
DSTM1726-STM1727 + - - 0.31+/20.11
DtrpA/trpB + pACYC1727-trpA - nd nd
nd: Not done;
#Reaction names is according to MetaCyc database [33].
¤LT2 gene numbers.
$
Growth phenotype is indicated as: +: growth as wild type strain, (+): growth observed but with rates below wild type strain, -: no growth observed.
£The media used as input in the model analysis and whether model prediction was considered true depended on the growth phenotype in this medium.
¥C.I.: competitive index of 1.00 corresponds to Wild type virulence.
#Prediction number in Table S2.
*Significantly different from WT strains.
**Significantly different from mutated strain without complementation.
doi:10.1371/journal.pone.0101869.t001
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mine, glycine, glutamine, proline, arginine, aspartate, glutamate
(M9+) as suggested [27]. Escherichia coli Top10 competent cells
were used for DNA cloning and were grown in LB media or on LB
agar plates at 37uC with appropriate selection.
Construction of strains and plasmids
Gene deletions and concomitant insertions of an antibiotic
resistance cassette were constructed using Lambda Red mediated
recombination as described elsewhere [28]. All constructs were
verified by PCR and moved into a clean background via P22
phage transduction as previously described [29]. Double mutant
strains were also constructed by P22-mediated transductions.
Primers used to construct mutants are listed in Table S1. The
genotype of mutants constructed appear in Table 1. Genetic
complementation of mutant in asnA/asnB was achieved by cloning
asnA into pSLD64, while genetic complementation of other genes
was achieved by PCR amplification and subsequent cloning of
genes into pACYC177, essentially as described [29]. Primers used
are listed in Table S1. Restriction enzymes used for cloning were
XhoI and BamHI. Enzymes were used according to the manufac-
turer’s recommendentation (Thermo Scientific). All constructs
were verified by restriction analysis and sequencing.
Mouse mixed infections
Female C57/BL6 mice (Nramp-) (20–25 g) were used to assess
in vivo fitness of bacterial strains as previously described [29].
Briefly, mice were inoculated I.P. with 0.1 ml of a 50:50 mixture of
wild type and mutated bacteria suspended in physiological saline.
To prepare the inoculum, strains were grown for 16 hrs, 200 rpm
at 37uC in LB media. Equal amounts of wild type and mutated
strains were mixed before the infection to give a challenge dose of
56103 bacteria of each strain. The exact c.f.u. and ratio between
wild type and mutated strains were enumerated by plating as
described below. Mice were killed at 6 days post-inoculation by
cervical dislocation. Severely affected animals were sacrificed early
to this time point for animal welfare reasons, but otherwise treated
as the rest of the group. The spleens were removed aseptically and
bacteria recovered and enumerated after plating a dilution series
on to LB agar. One hundred colonies were randomly picked and
tested for resistance to the relevant antibiotic to determine the
proportion of mutant strains. The competitive index was
calculated as the mutant/wild type ratio of the output versus the
mutant/wild type ratio of the inoculum.
Ethical statement
Mice experiments were conducted with permission from the
Danish Animal Experiments Inspectorate, license number: 2009/
561–1675.
Statistical analysis
Statistical significance of the differences between wild type and
mutant strains was determined using GraphPad Prism version 5.0
(GraphPad software) with one-sample t-test analysis. Grubb’s
outlier test was performed to exclude outliers with a significance of
0.05.
Simulation studies using a metabolic model
The model used, which contains 1099 reactions, has been
described elsewhere [21]. All model analysis was conducted
assuming a medium consisting of M9 added a number of non-
essential amino acids as detailed under growth experiments above.
The model was analyzed using Flux Balance Analysis [30,31], as
described previously [21]. The Linear Program (LP) was set to
minimize the flux-sum of the network, subject to steady-state
assumption, and the constraint that all biomass components must
be produced with biologically realistic rates, as stated in
equation 1.
minimize : IvI (objective function)
subject to : Nv~0 (steady - state)
vj~tj ; 0ƒjƒX (biomass production)
ð1Þ
where |v| is the absolute value of the flux vector, Nv = 0 expresses
the steady-state assumption, and vector t contains the rates of
export of biomass components from the network.
All model analysis was carried out using the ScrumPy package
[32]. Identification of cut sets reactions was done in two steps – (i)
all cut sets of size one were identified by attempting to solve
equation 1 with each reaction sequentially forced to carry zero flux
(except the trivial set involving all reactions in vector t); (ii) all two-
reaction combinations which were not supersets of reactions
identified in (i) were sequentially set to zero and combinations
which rendered the problem infeasible were recorded. For each
cut set the cause of the lethality was analyzed by identifying which
biomass components were not produced when the pair was
removed from the network. This was done by attempting to solve
the FBA (with a given pair fixed to zero flux) for each component
of vector t fixed to a non-zero value, whilst fixing all other
components to zero.
The gene associations of the selected reaction pairs were
obtained from the BioCyc database [33], through the PyoCyc
functionality of the ScrumPy package, as described in Hartman et
al. [21].
Results and Discussion
S. Typhimurium is an important intracellular pathogen of both
humans and animals causing self-limiting enteritis and life
threatening systemic infections. Replication and dissemination of
S. Typhimurium inside the host is essential for establishing a
systemic infection and is dependent on the ability to acquire and
utilize the nutrients available in this niche in addition to the ability
to synthesize essential nutrients that are only present in limited
concentrations [33]. S. Typhimurium causes a systemic disease in
susceptible mice, thus serving as a suitable model for studying
bacterial systemic infections [34].
Computational cut set analysis
A metabolic model of S. Typhimurium [21] was used to detect
cut sets of size two. The range of nutrients available to S.
Typhimurium at different points during the systemic stage of
infection is largely unknown, but contains glucose and certain
amino acids [35]. Recent studies have revealed that also other
carbohydrates constitute a suitable nutrient for S. Typhimurium
during infection [36]. The robustness of a metabolic model is
determined by the complexity of the media components assumed
to be available to the network, i.e. the number of external
metabolites, and the degree of redundancy of the network. S.
Typhimurium exhibits carbon catabolite repression [37], i.e. it
shows preference for glucose over other carbon sources. Still the
use of other carbon sources would change network performance,
because it will differ where the other carbon sources go in and
metabolites go out. However, block of the glucose catabolism, as
investigated in the current study, would also interfere with the
catabolism of other possible sources. Since the focus here was on
identification of cut sets, which were to be confirmed by biological
Redundancy and Virulence of S. Typhimurium
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experimentation, we used the pragmatic approach of assuming a
medium of minimal, but realistic complexity with glucose as the
carbon source.
The damage analysis resulted in a list of 102 reaction pairs
hampering the production of essential biomass components (Table
S2). The number of biomass components that were not produced
with a given cut set varied from one to all, with the distribution
shown in Figure 1. As can be seen in the figure, few cut sets had
the results that many components were not produced, while the
majority affected only few components. Two groups of cut sets
deviated from the general pattern. They were those that prevented
synthesis of two components and 24 components. The first group
was dominated by cut sets abolishing spermidine and putrescine
biosynthesis and abolished amino acid biosynthesis was also
prominent in this group. The second group involved predom-
inantly various combinations of reactions from the Entner-
Doudoroff and pentose phosphate pathway. Interestingly, genet-
ically redundant genes encode many of these highly detrimental
cut sets, and most sets in this group would require 5–6 gene
deletions in order to abolish their function. The initial 102 cut sets
were reduced to 63 by removing all sets where any reaction lacked
gene annotation.
A number of genes were predicted by the analysis to be essential
(i.e. they formed a cut-set of two reaction pairs where the same
gene encoded both reactions or they formed a cut-set together with
the (artificial) transporter reaction of a molecule synthesized by the
reaction (see Table S2). Five of these were selected to investigate
the preciseness of predictions, since literature studies are available
for essential genes in S. Typhimurium during systemic mouse
infection [38]: prsA, argD, fbp, adk and nadE.
The homolog of STM1780 (prsA) has been reported to be
conditional essential in E. coli [39], an viable E. coli null mutants
require additional mutations and several additional metabolites to
be viable [40]. In a global analysis of the importance of genes for
systemic Salmonella infection, prsA was not reported, suggesting that
prsA mutants are not viable [38]. Since this was the first gene to be
considered, we chose to confirm this observation. In support of the
model prediction, we could not produce a mutant in this gene,
despite several attempts, suggesting that the gene is essential in S.
Typhimurium under the conditions used for construction of
mutants.
argD encodes a bi-functional enzyme in arginine and lysine
biosynthesis [33]. This gene too, was not hit by Chadhuri et al. [38]
in their random mutation analysis, suggesting that it is essential
and cannot be analysed for virulence impact by mutational
analysis. fbp encodes a fructose-1, 6,bi-phosphatase, which
participates both in glycolysis and glyconeogenesis [33]. A
functional glycolysis pathway has been shown to be essential for
survival inside macrophages as well as for successful mouse
infection [3], and thus fbp must be considered essential for in vivo
fitness. The adelynate kinase encoded by adk participates in purine
and pyrimidine metabolism as well as adenoside nucleotide de novo
biosynthesis [33]. Strains with point mutations in the promoter or
coding region of this gene showed altered osmo-protection
phenotype [40], but to the best of our knowledge, no investigation
of the role in virulence has been performed. As for other genes
analysed here, no mutant hits were reported by Chadhuri et al.
[38]. nadE encodes an enzyme responsible for both glutamine
dependent and glutamine independent NAD+ synthesis [33], and
this enzyme was also not in the pool of transposon mutants [38].
Together, literature reports, previous studies of essential genes in
Salmonella mouse infection [38] and our own study of the gene prsA
suggested that model predictions were precise and that we could
proceed to more cumbersome testing of double lethal pairs.
Growth validation of model predictions
Among the 63 cut sets identified by the analysis, five cut sets
were selected for further analysis (Table 1). The cut sets were
picked among those that only involved two or three genes and
which abolished amino acid or polyamine biosynthesis. The focus
on cut sets with only two or three genes was done for practical
reasons, but with a view to future use as possible targets, it is also
most realistic to base this on simple combinations.
Figure 1. Frequency of biomass components predicted by the model to be affected by the 102 cut sets identified.
doi:10.1371/journal.pone.0101869.g001
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Genes in the selected reactions were subjected to mutational
analysis. Initially we tested growth of the mutants in vitro. The
growth phenotype was investigated by measuring the growth in
liquid rich media (LB), minimal media with glucose (M9) and M9
additionally supplemented with specific amino acids (M9+). The
composition of the latter medium corresponded to the input
provided in the computational cut set analysis. According to the
model analysis, single mutants should grow like the wild type
strain, whereas double-mutants were expected to be unable to
grow in M9+ as they would be auxotrophic for at least one
biomass component. Table 1 lists growth reactions of the cuts sets,
while growth performances in M9+ are shown graphically in
Figure S1.
Of the pairs tested, three (asnA/asnB; serA/glyA and thrC/kbl)
confirmed the cut set analysis since single mutants grew well in
M9+, while the double mutant did not grow. Contrary to this,
even the double mutant in the pair speB/speF,speC was not
attenuated for growth, while both single and double mutants of
trpA/trpB were affected for growth (Table 1 and Figure S1).
Investigation of attenuation of mutant strains
In vivo fitness of both single and double mutants was tested in the
mouse model of typhoid fever in competition with the isogenic
wild type parent. Bacterial load in the spleen of each mouse was
determined and the competitive index (C.I.) was calculated for
each infection pair (Table 1). The in vivo fitness of a mutant was
scored as low if the C.I. was less than 0.33 and/or significantly
different from 1.0. Based on these criteria, four double mutants
were less fit than the wild type strain (asnA/asnB; serA/glyA; trpA/
trpB and speB/speC,speF) indicating that these reaction pairs
contributed significantly to the fitness of the bacterium during
infection, while the double mutant thrC/kbl was unaffected.
Interestingly the single glyA mutant also proved attenuated, despite
its ability to grow in vitro (Table 1).
Details of individual reaction pairs
Based on these results, the predictions from the model analysis,
which related to growth phenotype in the M9+ media used as
input in the model, proved correct for three out of 5 cut sets.
However, with a view to identification of new targets for infection
control, the model analysis will always be considered an initial
screening step, and the in vivo testing is the important step. For this
part, four out of five predictions gave indications of in vivo
attenuation.
A clear set of phenotypes came from the analysis of the asnA and
asnB encoded enzymes. Both AsnA and AsnB catalyze the transfer
of aspartate to asparagine, although not iso-stoichiometriccally as
AsnA uses ammonia as a reactant, where AsnB predominantly
uses glutamine [33] (Figure S2). Both of the single mutants, but not
the double mutant could grow in media without asparagine
(Table 1). The reduction in the C.I. during I.P. infection of mice
showed that the asparagine availability during mouse infection is
not sufficient for growth of the double mutant. Complementation
of the virulence phenotype was obtained in the presence of a wild
type copy of the asnA gene on a plasmid (Table 1). Based on these
results, drugs targeting AsnA and AsnB constitute a potential new
anti-infective treatment approach.
A serine auxotroph in E. coli is able to grow with glycine as sole
precursor for serine synthesis. It was concluded that the
breakdown of glycine by the Gcv reaction is sufficient to generate
enough methylene-THF to reverse the GlyA reaction, thereby
synthesizing serine from glycine [41]. Serine is however also
synthesized from the glycolytic intermediate 3-phospho-glycerate
(3PG) by the action of the SerA/B/C reactions (Figure S3). In this
respect a serA/glyA double mutant should form a synthetic
auxotrophic couple in the presence of glycine due to serine
auxotrophy, while a serA or a glyA single mutant should grow fine.
This was confirmed by growing the mutants in minimal M9+
medium in the presence of glycine (Table 1 and Figure S1).
Further, as expected, the serA mutant had no infection defects, but
interestingly, the glyA mutant was severely affected with a C.I. of
2%. A likely explanation is that the Salmonella Gcv system does not
generate a sufficient C1 flux at the levels of glycine available
during infection. In support of this, Stauffer and co-workers [42]
found that the Gcv activity in S. Typhimurium is only 20% of the
level found in E. coli, but further studies are needed to clarify
whether reduced C1-flux is causing attenuation of the glyA-mutant.
In conclusion, it appears from the virulent serA mutant that serine
is available during infection, and in amounts not limiting the C1
flux. However the attenuated glyA mutant indicates that glycine is
not present in sufficient amounts during infection, for the
inefficient Gcv system to fuel the C1-flux. This conclusion requires
that gcv is indeed functionally active, since alternatively Salmonella
relies on GlyA for C1-fueling. Studies of gene expression show that
the gvc-operon is up-regulated in S. Typhimurium after 8 hours in
cultured macrophages, which suggest that it may be active [7].
Irrespective of the explanation, the observation makes GlyA a
promising single target for drug discovery.
Threonine can be synthesized in two ways aside from the
threonine biosynthesis pathways. Both of these auxiliary reactions
use glycine as precursor. Threonine may be formed in a single step
from glycine and acetaldehyde catalyzed by the ltaA gene product.
Alternatively it may be formed in two steps by the kbl and thr gene
products. In the biosynthetic pathway, threonine is formed from
homoserine through the action of ThrB and ThrC. Threonine
subsequently functions as a precursor for the synthesis of isoleucine
by the action of the ilvA – ilvD gene products. In a classical genetic
analysis, Glanville & Demerec [43] found that a thrC mutant in
strain LT2 (at that time called a thrE mutant) requires either
threonine or isoleucine for growth. The fact that isoleucine can
support growth of the thrC mutant without being converted to
threonine is an indication that the threonine flux from glycine is
enough to supply threonine-charged tRNAs for protein synthesis.
Since the flux of threonine from glycine was not sufficient to
support growth of the thrC mutant in the absence of Isoleucine, we
expected that either the LtaA reaction or the Kbl/Thr path was
nonfunctional. We considered the thrC/kbl pair suggested by the
model analysis as a cut set. In our strain we found that a thrC
mutant grew somewhat slower than the wild type, while a kbl strain
had no growth related phenotypes. The thrC/kbl double mutant
however was unable to grow in minimal medium without
threonine supplements, showing that the mutant pair is truly
auxotrophic. Interestingly, however, we did not observe any clear
infection defect as shown by the C.I. values of either single or
double mutants. This confirms that the host must supplies
sufficient threonine during all phases of the infection, as recently
reported [36].
Approximately 28 reaction pairs predicted by the model
analysis are involved in the production of putrescine and/or
spermidine (Table S2). Putrescine and spermidine are small
polycationic amines of the group polyamines. Putrescine is
synthesized via agmatine from arginine by the speA and speB gene
products or directly from ornithine by either of the speC or speF
gene products. Putrescine can subsequently be converted into
spermidine by the co-action of the speE and speD gene products
(Figure S4). From the 28 reaction pairs suggested by the model, we
analyzed the the effect of combined removal of AGMATIN-RXN
and ORNDECOBON-RXN by creating a speB mutant, a speC/
Redundancy and Virulence of S. Typhimurium
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speF double mutant, and a speB/speC/speF triple mutant. The triple
mutant was not impaired for growth in either rich (LB) or the two
M9 media (Table 1) showing that the reactions do not constitute a
cut set combination even in the absence of putrescine. However,
while a speB mutant and a speC/speF mutant had close to wild type
C.I.’s, the triple mutant had a severe infection defect pointing to
the importance of putrescine availability for virulence. We have
previously shown that a mutant lacking speB, speC, speF and speE is
attenuated for virulence signifying that polyamines play a role in
virulence of S. Typhimurium [29]. However, the quadruple
mutant investigated in Jelsbak et al. [29] had a reduced growth rate
in M9 suggesting that growth rate could be a contributing factor to
the virulence attenuation. In the present study, we show that the
speB/speC/speF triple mutant, which had no growth defect, was still
attenuated in mice, thus substantiating the essential roles for
polyamines in virulence of S. Typhimurium. It has recently been
reported that polyamines also contribute to virulence of Shigella spp
and Legionella pneumophila, [44,45]. Drugs targeting SpeB, SpeC,
and SpeF are hence promising candidates for new broad-spectrum
antimicrobials.
Finally, trpA and trpB were predicted to form a cut set (Table 1
and Table S2). They form a bienzyme-complex, which is capable
of performing three reactions: 1) the cleavage of indole-3-glycerol
phosphate to indole and glyceraldehyde-3-phosphate, 2) the
formation of L-tryptophan from L-serine and indole, and 3) the
formation of tryptophan from L-serine and indole-2-glycerol
phosphate [33]. Activity in E. coli has been shown to be
significantly higher when these two enzymes work in conjunction
rather than as individual enzymes [46]. This observation was
confirmed for S. Typhimurium in the current investigation, since
both the single and the double mutants were growth attenuated in
M9+ medium (Figure S1), suggesting that activity of both enzymes
are needed for full growth in the medium used as input to the
model. Growth was restored to wild type levels when the trpA
mutant was complemented with trpA wild-type allele in trans, while
trpB still showed reduced growth-rate (but reached wild type
density) when complemented by the wild type allele in trans. As
expected, complementation of the double mutant with single genes
was unsuccessful. Single gene knock-outs were without impact on
fitness in vivo, while the double mutant could not compete with the
wild type strains. The most obvious explanation for this
observation is that tryptophan is not provided by the host during
S. Typhimurium infection. However, the observation contradicts a
previous observation by Steeb et al. [36] who considered that
tryptophan is not essential for growth of S. Typhimurium during
infection. In support of our conclusion, Henry et al. [47], in a study
of genes important for cell division of S. Typhimurium in cell
cultures, observed that lack of TrpC, which performs the step
above the one by TrpB/TrpA in the biosynthesis of trypophane,
caused formation of filamentous cells, and thus this enzyme
appeared essential for in vivo growth. However, further studies are
indicated to clarify this matter.
Concluding remarks
In the present study we have used genome scale metabolic
modeling to identify pairs of reactions in S. Typhimurium required
for intra host survival. Our results revealed that asparagine,
tryptophan and most likely glycine are not present in sufficient
amounts to support growth while threonine and serine are. These
data add to the existing knowledge of available nutrients in the
intra-host environment [9–12,36]. In the recent paper by Steeb et
al. [36], a comprehensive analysis including mutagenesis of intra
host expressed enzymes was used to identify available metabolites
in the host. Compared to their study, we confirm the availability of
threonine, however, in contrast, we found that most likely glycine
and tryptophane are only present in limiting amounts, as the glyA
mutant and the trpA;trpB double mutant had reduced competitive
fitness compared to the wild type. The conclusion regarding the
glyA mutant should be further substantiated by studies comparing
GlyA and GCV performance. Furthermore, we additionally found
that asparagine and putrescine are only present in limiting
amounts during infection. This is particularly interesting since
the SpeB, SpeC, and SpeF enzymes, facilitating putrescine
biosynthesis, were not detected in Salmonella bacteria isolated from
spleens [36]. We have previously reported the essential role of
polyamines in virulence of S. Typhimurium [29], however, the
present results show that polyamines are not required for growth
in vitro, indicating that they are more specifically related to
virulence than to central metabolism. The putrescine biosynthetic
genes constitute a novel target for anti-infective therapy with
potential of broad effect against several intracellular pathogens.
Supporting Information
Figure S1 Growth phenotypes of five selected cut sets in
M9 media with supplements (see text). The media
corresponds to the one used as input in the cut set analysis using
the S. Typhimurium genome scale model.
(PDF)
Figure S2 The transformation of L-asparatate to L-
asparagine catalyzed by the reactions of AsnA and AsnB.
AsnA uses ammonia as a reactant where AsnB predominantly uses
glutamine.
(PDF)
Figure S3. The biosynthesis of serine. Serine can be
produced from glycine through the action of GlyA and also from
3-phospo-glycecerate (3PG) by the action of SerA/B/C.
(PDF)
Figure S4. The polyamine biosynthesis pathways in
Salmonella. Putrescine can be formed from arginine through the
reactions catalyzed by SpeA and SpeB and from ornithine through
the reaction catalyzed by SpeC/SpeF. Spermidine is formed from
putrescine through the reactions of SpeE and SpeD.
(PDF)
Table S1 Primers used for construction of mutants and
for cloning purposes.
(PDF)
Table S2 A list of 102 reaction pairs identified as
unfeasible for production of essential biomass in the
damage analysis.
(PDF)
Acknowledgments
Professor David Fell, Department of Medical and Biological Sciences,
Oxford Brookes University, UK is thanked for very constructive guidance
and discussion during the current study. Tanja Kristensen and Tony
Bønnelycke are thanked for valuable technical assistance.
Author Contributions
Conceived and designed the experiments: LJ HH MK LET PRJ JEO.
Performed the experiments: LJ HH CS JTR SL IW. Analyzed the data: LJ
HH MP JEO. Contributed reagents/materials/analysis tools: MP JEO.
Contributed to the writing of the manuscript: LJ HH JEO.
Redundancy and Virulence of S. Typhimurium
PLOS ONE | www.plosone.org 6 July 2014 | Volume 9 | Issue 7 | e101869
References
1. Mwangi MM, Wu SW, Zhou Y, Sieradzki K, de Lencastre H, et al. (2007)
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by
whole-genome sequencing. Proc Natl Acad Sci USA 104: 9451–9456.
2. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, et al. (2013) Emergence
and global spread of epidemic healthcare-associated Clostridium difficile. Nat
Genet 45: 109–113.
3. Bowden SD, Rowley G, Hinton JC, Thompson A (2009) Glucose and glycolysis
are required for the successful infection of macrophages and mice by Salmonella
enterica serovar typhimurium. Infect Immun 77: 3117–3126.
4. McKinney JD, Ho¨ner zu Bentrup K, Mun˜oz-Elı´as EJ, Miczak A, et al. (2000)
Persistence of Mycobacterium tuberculosis in macrophages and mice requires the
glyoxylate shunt enzyme isocitrate lyase. Nature 406: 735–738.
5. Munoz-Elias EJ, McKinney JD (2005) Mycobacterium tuberculosis isocitrate lyases 1
and 2 are jointly required for in vivo growth and virulence. Nat Med 11: 638–
644.
6. Chico-Calero I, Suarez M, Gonzalez-Zorn B, Scortti M, Slaghuis J, et al. (2002)
Hpt, a bacterial homolog of the microsomal glucose-6-phosphate translocase,
mediates rapid intracellular proliferation in Listeria. Proc Natl Acad Sci USA 99:
431–436.
7. Eriksson S, Lucchini S, Thompson A, Rhen M, Hinton JC (2003) Unravelling
the biology of macrophage infection by gene expression profiling of intracellular
Salmonella enterica. Mol Microbiol 47: 103–118.
8. Hautefort I, Thompson A, Eriksson-Ygberg S, Parker ML, Lucchini S, et al.
(2008) During infection of epithelial cells Salmonella enterica serovar Typhimurium
undergoes a time-dependent transcriptional adaptation that results in simulta-
neous expression of three type 3 secretion systems. Cell Microbiol 10: 958–984.
9. Hoiseth SK, Stocker BA (1981) Aromatic-dependent Salmonella typhimurium are
non-virulent and effective as live vaccines. Nature 291: 238–239.
10. Sigwart DF, Stocker BA, Clements JD (1989) Effect of a purA mutation on
efficacy of Salmonella live-vaccine vectors. Infect Immun 57: 1858–1861.
11. Bogard RW, Davies BW, Mekalanos JJ (2012) MetR-regulated Vibrio cholerae
metabolism is required or virulence. MBio 3: e00236–12.
12. Cersini A, Salvia AM, Bernardini ML (1998) Intracellular multiplication and
virulence of Shigella flexneri auxotrophic mutants. Infect Immun 66: 549–557.
13. Becker D, Selbach M, Rollenhagen C, Ballmaier M, Meyer TF, et al. (2006)
Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature
440: 303–307.
14. Bumann D (2008) Has nature already identified all useful antibacterial targets?
Curr Opin Microbiol 11: 387–392.
15. Raghunathan A, Reed J, Shin S, Palsson B, Daefler S (2009) Constraint-based
analysis of metabolic capacity of Salmonella typhimurium during host-pathogen
interaction. BMC Syst Biol 3: 38.
16. Thiele I, Hyduke DR, Steeb B, Fankam G, Allen DK, et al. (2011) A community
effort towards a knowledge-base and mathematical model of the human
pathogen Salmonella Typhimurium LT2. BMC Syst Biol 5: 8.
17. O’Connor TJ, Boyd D, Dorer MS, Isberg RR (2012) Aggravating genetic
interactions allow a solution to redundancy in a bacterial pathogen. Science 338:
1440–1444.
18. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL (2007) Drugs for bad bugs:
confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6:
29–40.
19. Klamt S, Gilles ED (2004) Minimal cut sets in biochemical reaction net-works.
Bioinform 20: 226–234.
20. Papp B, Notebaart RA, Pal C (2011) Systems-biology approaches for predicting
genomic evolution. Nat Rev Genet 12: 591–602.
21. Hartman HB, Fell DA, Rossel S, Jensen PR, Woodward MJ, et al. (2013)
Identification and damage analysis of a catabolic core in a genome-scale model
of Salmonella Typhimurium by variation of energy demand. Microbiol 160:
1252–1266.
22. Jamshidi N, Palsson BO (2008) Formulating genome-scale kinetic models in the
post-genome era. Mol Syst Biol 4: 171.
23. Smallbone K, Simeonidis E, Broomhead D, Kell D (2007) Something from
nothing; bridging the gap between constraint-based and kinetic modeling.
FEBS J 274: 5576–5585.
24. Durot M, Bourguignon P-Y, Schachter V (2009) Genome-scale models of
bacterial metabolism: reconstruction and applications. FEMS Microbiol Rev 33:
164–190.
25. Wallis TS, Paulin SM, Plested JS, Watson PR, Jones PW (1995) The Salmonella
dublin virulence plasmid mediates systemic but not enteric phases of salmonellosis
in cattle. Infect Immun 63: 2755–2761.
26. Enomoto M, Stocker BA (1974) Transduction by phage P1kc in Salmonella
typhimurium. Virology 60: 503–514.
27. Fu¨rst P, Stehle P (2004) What are the essential elements needed for the
determination of amino acid requirements in humans? J Nutr 134: 1558S-
1565S.
28. Datsenko KA, Wanner BL (2000) One step inactivation of chromosomal genes
in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640–
6645.
29. Jelsbak L, Thomsen LE, Wallrodt I, Jensen PR, Olsen JE (2012) Polyamines are
required for virulence in Salmonella enterica Serovar Typhimurium. PLoS ONE 7:
e36149.
30. Fell DA, Small JR (1986) Fat synthesis in adipose tissue. Biochem J 238: 781–
786.
31. Varma A, Palsson BO (1993) Metabolic capabilities of Escherichia coli: I. Synthesis
of biosynthetic precursors and cofactors. J Theor Biol 165: 477–502.
32. Poolman MG (2006) ScrumPy-metabolic modelling with Python. IEE Proc
System Biol 153: 375–378.
33. Portillo FGD (2001) Salmonella intracellular proliferation: where, when and how?
Microb Infect 3: 1305–1311.
34. Caspi R, Foerster H, Fulcher C, Kaipa P, Krummenacker M, et al. (2007) The
MetaCyc Database of metabolic pathways and enzymes and the BioCyc
collection of Pathway/Genome Databases. Nucleic Acids Res 36: D623–D631.
35. Haraga A, Ohlson MB, Miller SI (2008) Salmonellae interplay with host cells.
Nat Rev Microbiol 6: 53–66.
36. Go¨tz A, Eylert E, Eisenreich W, Goebel W (2010) Carbon metabolism of
enterobacterial human pathogens growing in epithelial colorectal adenocarci-
noma (Caco-2) cells. PLoS ONE 5: e10586.
37. Steeb B, Claudi B, Burton NA, Tienz P, Schmidt A, et al. (2013) Parallel
exploitation of diverse host nutrients enhances salmonella virulence. PLoS
Pathog 9: e1003301.
38. Gorke B, Stulke J (2008) Carbon catabolite repression in bacteria: many ways to
make the most out of nutrients. Nat Rev Micro 6: 275–281.
39. Chaudhuri RR, Peters SE, Pleasance SJ, Northen H, Willers C, et al. (2009)
Comprehensive identification of Salmonella enterica serovar Typhimurium genes
required for infection of BALB/c mice. PLoS Pathogen 5: e1000529.
40. Chen J, Brevet A, Fromant M, Le´veˆque F, Schmitter J-M, et al. (1990)
Pyrophosphatase is essential for growth of Escherichia coli. J Bac 172: 5686–
5689.
41. Hove-Jensen B (1988) Mutation in the phosphoribosylpyrophosphate synthetase
gene (prs) that results in simultaneous requirements for purine and pyrimidine
nucleosides, nicotinamide nucleotide, histidine, and tryptophan in Escherichia
coli. J Bac 170: 1448–1152.
42. Pitzer LI, Potochny ML (1964) Nutritional and regulatory aspects of serine
metabolism in Escherichia coli. J Bac 88: 611–619.
43. Stauffer GV, Stauffer LT, Plamann MD (1989) The Salmonella typhimurium
glycine cleavage enzyme system. Mol Gen Genet 220: 154–156.
44. Glanville EV, Demerec M (1960) Threonine, Isoleucine, and Isoleucine-Valine
mutants of Salmonella typhimurium. Genet 45: 1359–1374.
45. Barbagallo M, Di Martino ML, Marcocci L, Pietrangeli P, De CE, et al. (2011)
A new piece of the Shigella pathogenicity puzzle: Spermidine accumulation by
silencing of the speG gene. PLoS ONE 6: e27226.
46. Nasrallah GK, Riveroll AL, Chong A, Murray LE, Lewis PJ, et al. (2011)
Legionella pneumophila requires polyamines for optimal intracellular growth. J Bac
193: 4346–4360.
47. Kirschner K, Lane AN, Strasser AW (1991) Reciprocal communication between
the lyase and synthase active sites of the tryptophan synthase bienzyme complex.
Biochem 15: 472–478.
48. Henry T, Garcia-del Portillo F, Gorvel JP (2005) Identification of Salmonella
functions critical for bacterial cell division within eukaryotic cells. Mol Microbiol
56: 252–267.
Redundancy and Virulence of S. Typhimurium
PLOS ONE | www.plosone.org 7 July 2014 | Volume 9 | Issue 7 | e101869
